LP
Lipella Pharmaceuticals Inc. Common Stock
🇺🇸XNAS.LIPOUnited StatesHealthcare
$0.00USDunchanged 0.00OpenEnd of day4:19 PM
Price$0.000.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US53630L2097
- CUSIP
- 53630L209
Company
- Employees
- 5
- Headquarters
- Pittsburgh, United States
- Website
- https://lipella.com
- CEO
- Dr. Jonathan Kaufman M.B.A., Ph.D.
Market
- Shares outstanding
- 4.6M
- Market cap
- $0
Highlights
No high and low reported for today's session.
- Market cap
- $0
- EPS LTM
- -$1.15calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $216.29M+26,526.68%up year on year
- Net income
- -$5.33M-25.01%down year on year
- Gross margin
- 98.35%+136.43%up year on year
- Free cash flow
- -$2.36B-63,934.26%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.